AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Bristol Myers' Cobenfy, the first new schizophrenia treatment in decades, shows early sales momentum and strong pipeline ...

Evolus Inc. lost a third of its value after lower-than-expected second quarter results, reflecting weakened demand within the ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

Key drivers in the dementia and movement disorder treatment market include a growing geriatric population and new public awareness strategies. The report features a detailed analysis of major vendors ...

The global monoclonal antibody therapeutics market is set to witness a growth rate of ~12% in the next 5 years. Rising ...

Glenmark Pharmaceuticals to close ISB 2001 transaction in September, focusing on high-margin branded products for growth.

The Global Women’s Health Market is expected to witness a growth rate of 4-5% in the next five years. Growing incidence of ...

Analysts are intrested in these 5 stocks: ( ($ABBV) ), ( ($DOW) ), ( ($KTOS) ), ( ($RKT) ) and ( ($AMAT) ). Here is a breakdown of their recent ...

AbbVie Inc. has turned heads recently with a notable uptick in stock searches. Over the last month, its shares soared by +9.2 ...